Tissue-Specific Sequence Alterations in the Human Immunodeficiency Virus Type 1 Envelope Favoring CCR5 Usage Contribute to Persistence of Dual-Tropic Virus in the Brain

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Virology

• Publication date

  2009-03-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.02648-08PMID 19321618PMCID PMC2681927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preclinical assessment of the distribution of maraviroc to potential human immunodeficiency virus (HIV) sanctuary sites in the central nervous system (CNS) and gut-associated lymphoid tissue (GALT).

  2008cited by this paper
• Bioinformatic Prediction Programs Underestimate the Frequency of CXCR4 Usage by R5X4 HIV Type 1 in Brain and Other Tissues

  2008influential reference
• Maraviroc for previously treated patients with R5 HIV-1 infection.

  2008cited by this paper
• Phase II study of vicriviroc versus efavirenz (both with zidovudine/lamivudine) in treatment-naive subjects with HIV-1 infection.

  2008cited by this paper
• Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

  2008cited by this paper
• Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

  2008cited by this paper
• Structural Basis for Coreceptor Selectivity by The HIV Type 1 V3 Loop

  2007cited by this paper
• Phenotypic assays for the determination of coreceptor tropism in HIV-1 infected individuals.

  2007cited by this paper
• Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.

  2007cited by this paper
• V3 Loop Truncations in HIV-1 Envelope Impart Resistance to Coreceptor Inhibitors and Enhanced Sensitivity to Neutralizing Antibodies

  2007cited by this paper
• Antiviral activity, pharmacokinetics and safety of vicriviroc, an oral CCR5 antagonist, during 14-day monotherapy in HIV-infected adults

  2007cited by this paper
• Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates

  2007cited by this paper
• Improved prediction of coreceptor usage and phenotype of HIV-1 based on combined features of V3 loop sequence using random forest.

  2007cited by this paper
• Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.

  2007cited by this paper
• The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo1

  2007cited by this paper
• Genetic and Functional Analysis of R5X4 Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Derived from Two Individuals Homozygous for the CCR5Δ32 Allele

  2006cited by this paper
• Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele.

  2006cited by this paper
• The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia

  2006cited by this paper
• Mechanisms of HIV-1 neurotropism.

  2006cited by this paper
• SPECIES DIFFERENCES IN THE DISPOSITION OF THE CCR5 ANTAGONIST, UK-427,857, A NEW POTENTIAL TREATMENT FOR HIV

  2005cited by this paper
• Pathogenesis of macrophage tropic HIV-1.

  2005cited by this paper
• Variants of Human Immunodeficiency Virus Type 1 That Efficiently Use CCR5 Lacking the Tyrosine-Sulfated Amino Terminus Have Adaptive Mutations in gp120, Including Loss of a Functional N-Glycan

  2005cited by this paper
• Structure of a V3-Containing HIV-1 gp120 Core

  2005cited by this paper
• Preferential Use of CXCR4 by R5X4 Human Immunodeficiency Virus Type 1 Isolates for Infection of Primary Lymphocytes

  2005cited by this paper
• Adjunctive therapies for HIV-1 associated neurologic disease

  2005cited by this paper
• The neuropathogenesis of AIDS

  2005cited by this paper
• Antiretroviral therapy in HIV infection: are neurologically active drugs important?

  2004influential reference
• Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonis

  2004cited by this paper
• Coevolution of RANTES Sensitivity and Mode of CCR5 Receptor Use by Human Immunodeficiency Virus Type 1 of the R5 Phenotype

  2004cited by this paper
• Characterization of the Outer Domain of the gp120 Glycoprotein from Human Immunodeficiency Virus Type 1

  2004cited by this paper
• Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

  2003cited by this paper
• Genetic and Functional Analysis of Full-Length Human Immunodeficiency Virus Type 1 env Genes Derived from Brain and Blood of Patients with AIDS

  2003influential reference
• Improved Coreceptor Usage Prediction and GenotypicMonitoring of R5-to-X4 Transition by Motif Analysis of HumanImmunodeficiency Virus Type 1 env V3 LoopSequences

  2003cited by this paper
• Increased CCR5 Affinity and Reduced CCR5/CD4 Dependence of a Neurovirulent Primary Human Immunodeficiency Virus Type 1 Isolate

  2002influential reference
• The challenge of viral reservoirs in HIV-1 infection.

  2002cited by this paper
• The Crown and Stem of the V3 Loop Play Distinct Roles in Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Interactions with the CCR5 Coreceptor

  2002cited by this paper
• Improved Elicitation of Neutralizing Antibodies against Primary Human Immunodeficiency Viruses by Soluble Stabilized Envelope Glycoprotein Trimers

  2001cited by this paper
• Pathways to neuronal injury and apoptosis in HIV-associated dementia

  2001cited by this paper
• Macrophage Tropism of Human Immunodeficiency Virus Type 1 Isolates from Brain and Lymphoid Tissues Predicts Neurotropism Independent of Coreceptor Specificity

  2001influential reference
• Adaptive Mutations in the V3 Loop of gp120 Enhance Fusogenicity of Human Immunodeficiency Virus Type 1 and Enable Use of a CCR5 Coreceptor That Lacks the Amino-Terminal Sulfated Region

  2001cited by this paper
• Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks.

  2001cited by this paper
• Varied tropism of HIV-1 isolates derived from different regions of adult brain cortex discriminate between patients with and without AIDS dementia complex (ADC): evidence for neurotropic HIV variants.

  2001cited by this paper
• Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection.

  2000influential reference
• Envelope Glycoprotein Determinants of Increased Fusogenicity in a Pathogenic Simian-Human Immunodeficiency Virus (SHIV-KB9) Passaged In Vivo

  2000cited by this paper
• Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.

  2000cited by this paper
• Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis.

  2000cited by this paper
• The plasma membrane as a combat zone in the HIV battlefield.

  2000influential reference
• Latency and reservoirs for HIV-1.

  1999cited by this paper
• Granulocyte-macrophage colony-stimulating factor and fluconazole enhance anti-cryptococcal activity of monocytes from AIDS patients.

  1999cited by this paper
• Identification of CXCR4 Domains That Support Coreceptor and Chemokine Receptor Functions

  1999cited by this paper
• Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein.

  1999cited by this paper
• HIV-1 envelope determinants for cell tropism and chemokine receptor use.

  1999cited by this paper
• Role of CXCR4 in Cell-Cell Fusion and Infection of Monocyte-Derived Macrophages by Primary Human Immunodeficiency Virus Type 1 (HIV-1) Strains: Two Distinct Mechanisms of HIV-1 Dual Tropism

  1999cited by this paper
• Effect of Mutations in the Second Extracellular Loop of CXCR4 on Its Utilization by Human and Feline Immunodeficiency Viruses

  1999cited by this paper
• Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.

  1999cited by this paper
• Lymphotropic Virions Affect Chemokine Receptor-Mediated Neural Signaling and Apoptosis: Implications for Human Immunodeficiency Virus Type 1-Associated Dementia

  1999cited by this paper
• Chemokine receptors and virus entry in the central nervous system.

  1999cited by this paper
• Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1

  1998cited by this paper
• Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity.

  1998cited by this paper
• A Tyrosine-Rich Region in the N Terminus of CCR5 Is Important for Human Immunodeficiency Virus Type 1 Entry and Mediates an Association between gp120 and CCR5

  1998cited by this paper
• Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1

  1997cited by this paper
• HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

  1996cited by this paper
• HIV Type 1 V3 Sequences and the Development of Dementia during AIDS

  1996cited by this paper
• HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

  1996cited by this paper
• CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

  1996cited by this paper
• Sequence Analysis of the V3 Loop in Brain and Spleen of Patients with HIV Encephalitis

  1996cited by this paper
• Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization

  1996cited by this paper
• Syncytium‐inducing phenotype and zidovudine susceptibility of HIV‐1 isolated from post‐mortem tissue

  1996cited by this paper
• CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1

  1996cited by this paper
• Isolation and characterization of human immunodeficiency virus type 1 variants infectious to brain-derived cells: detection of common point mutations in the V3 region of the env gene of the variants

  1994cited by this paper
• Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences

  1994cited by this paper
• An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1

  1992cited by this paper
• Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism

  1992cited by this paper
• Patients with

  1987cited by this paper
• The role of mononuclear phagocytes in HTLV-III/LAV infection.

  1986cited by this paper
• Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS.

  1986cited by this paper
• Edinburgh Research Explorer Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion

  year unknowncited by this paper

• A Canadian Survey of Research on HIV-1 Latency—Where Are We Now and Where Are We Heading?

  2024cites this paper
• Cell-to-Cell Transmission of HIV-1 and HIV-2 from Infected Macrophages and Dendritic Cells to CD4+ T Lymphocytes

  2023cites this paper
• Antiretroviral therapy intensification for HIV-associated neurocognitive disorder?

  2023cites this paper
• Resistance to HIV-1 Infection Conferred by a Compound CCR5Δ32 and CCR5 C20S Heterozygote.

  2023cites this paper
• Uptake of Biotinylated Spermine in Astrocytes: Effect of Cx43 siRNA, HIV-Tat Protein and Polyamine Transport Inhibitor on Polyamine Uptake

  2021cites this paper
• Longitudinal analysis of subtype C envelope tropism for memory CD4+ T cell subsets over the first 3 years of untreated HIV-1 infection

  2020cites this paper
• HIV-1 persistence in the central nervous system: viral and host determinants during antiretroviral therapy.

  2019cites this paper
• CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4+ T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and Maintained

  2019cites this paper
• Futuristic Methods for Determining HIV Co-receptor Use

  2019cites this paper
• Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders

  2018cites this paper
• Human Immunodeficiency Virus and the Nervous System.

  2018cites this paper
• CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study

  2018cites this paper
• Neruodevelopmental Outcomes in Preschool Children Living With HIV-1 Subtypes A and D in Uganda

  2018cites this paper
• Resolving the Sites of HIV Entry: Dynamin Networks Hold the Key

  2017influential citation
• Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality

  2017cites this paper
• Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 Antagonists

  2017cites this paper
• HIV-associated synaptic degeneration

  2017cites this paper
• Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study

  2017influential citation
• HIV-1 gp120Bal down-Regulates Phosphorylated NMDA Receptor Subunit 1 in Cortical Neurons via Activation of Glutamate and Chemokine Receptors

  2016cites this paper
• Tissue Compartmentalization and Tropism of HIV-1: A Dissertation

  2016cites this paper
• Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc

  2016cites this paper
• Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder

  2016cites this paper
• Strategies to target HIV-1 in the central nervous system

  2016cites this paper
• A HIV-Tat/C4-binding protein chimera encoded by a DNA vaccine is highly immunogenic and contains acute EcoHIV infection in mice

  2016cites this paper
• Investigating the feasibility of incorporating Vpx into lentiviral gene therapy vectors: at a global and targeted scale

  2016cites this paper
• Longitudinal Analysis of Cerebrospinal Fluid and Plasma HIV-1 Envelope Sequences Isolated From a Single Donor with HIV Asymptomatic Neurocognitive Impairment.

  2015cites this paper
• CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies

  2015cites this paper
• Role of Macrophages in the Immunopathogenesis of HIV-1 Infection

  2015cites this paper
• HIV‐1 envelope–receptor interactions required for macrophage infection and implications for current HIV‐1 cure strategies

  2014cites this paper
• Bioinformatic analysis of HIV-1 entry and pathogenesis.

  2014cites this paper
• Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4+ T-cell subsets, including stem cell memory T-cells

  2014cites this paper
• Activation of TRPML1 Clears Intraneuronal Aβ in Preclinical Models of HIV Infection

  2014cites this paper
• Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope

  2014cites this paper
• Understanding mechanisms of HIV-1 entry into cells

  2014cites this paper
• Dual-mixed HIV-1 coreceptor tropism and HIV-associated neurocognitive deficits

  2013cites this paper
• HIV Associated Neurocognitive Disorders

  2013cites this paper
• A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations

  2013cites this paper
• Glycosylation in HIV-1 envelope glycoprotein and its biological implications

  2013cites this paper
• Macrophage‐tropic HIV‐1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5

  2013influential citation
• The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets.

  2013cites this paper
• Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection

  2013cites this paper
• Genetic Signatures of HIV-1 Envelope-mediated Bystander Apoptosis

  2013cites this paper
• Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12.

  2012cites this paper
• Molecular and Bioinformatic Analysis of Neurotropic HIV Envelope Glycoproteins

  2012cites this paper
• HIV-1 Escape from the CCR5 Antagonist Maraviroc Associated with an Altered and Less-Efficient Mechanism of gp120-CCR5 Engagement That Attenuates Macrophage Tropism

  2011cites this paper
• The chemokine receptor CCR5 in the central nervous system.

  2011cites this paper
• Viral Determinants of HIV-1 Macrophage Tropism

  2011cites this paper
• Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia

  2011cites this paper
• Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues

  2011cites this paper
• How much do antiretroviral drugs penetrate into the central nervous system?

  2011cites this paper
• Alternative Coreceptor Requirements for Efficient CCR5- and CXCR4-Mediated HIV-1 Entry into Macrophages

  2011influential citation
• Coreceptors and HIV-1 Pathogenesis

  2011cites this paper
• HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children

  2010influential citation
• Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection.

  2010cites this paper
• Identification and Characterization of Persistent Intracellular Human Immunodeficiency Virus Type 1 Integrase Strand Transfer Inhibitor Activity

  2010cites this paper
• Regulation of CCR5 use on primary CD4+ lymphocytes by R5X4 HIV-1

  2010cites this paper
• Reviewmechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection

  2010cites this paper
• M‐tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T‐tropic gp120 in rat striatum

  2010cites this paper
• Identification and characterization of persistent intracellular human 1 immunodeficiency virus type 1 integrase strand transfer inhibitor activity 2 3 4

  2010cites this paper
• Morphine induces the release of CCL5 from astrocytes: Potential neuroprotective mechanism against the HIV protein gp120

  2010cites this paper
• An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes.

  2010cites this paper
• Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry.

  2010cites this paper
• Open Access Review Molecular Mechanisms of Neuroinvasion by Monocytes-macrophages in Hiv-1 Infection

  year unknowncites this paper